Gilead Sciences (GILD) Tops Q2 EPS by 44c
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $152.67 --0%
Revenue Growth %: -0.4%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -0.4%
Financial Fact:
Net income: 3.33B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $3.15, $0.44 better than the analyst estimate of $2.71. Revenue for the quarter came in at $8.24 billion versus the consensus estimate of $7.61 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
- CarMax (KMX) PT Raised to $47 at Morgan Stanley
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
